Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension tags : Positive save search
Ionis presents positive two-year results from the Phase 2 open label extension study of donidalorsen in patients with hereditary angioedema
Published: 2023-11-09 (Crawled : 21:00) - ionispharma.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.53%
H: 0.38%
C: -2.52%
label positive extension results study
Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
CLSD P | $1.29 -2.27% -2.33% 230K
|
Health Technology
|
| O: 2.44%
H: 4.31%
C: 1.44%
positive retina meeting extension study
Incyte Announces Positive 52-Week Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo
Published: 2023-10-11 (Crawled : 13:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.45%
H: 0.52%
C: -0.94%
incb5470 positive study
Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension
Published: 2023-08-21 (Crawled : 13:20) - biospace.com/
ANEB | $2.85 -7.14% 710
|
Manufacturing
|
| O: 7.5%
H: 12.62%
C: 2.66%
aneb-001 fda positive extension
Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for Ulixacaltamide
Published: 2023-08-08 (Crawled : 11:00) - globenewswire.com
PRAX | $46.88 0.62% 0.62% 350K
|
Health Technology
|
| O: 0.76%
H: 3.87%
C: 3.87%
positive extension study
Capricor Therapeutics Announces Positive 24-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
Published: 2023-06-30 (Crawled : 13:00) - globenewswire.com
CAPR | $5.01 -0.79% -0.8% 350K
|
Health Technology
|
| O: 1.46%
H: 0.23%
C: -1.85%
cap-1002 label positive ongoing extension therapeutics duchenne results study
Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023
Published: 2023-02-22 (Crawled : 22:00) - globenewswire.com
FOLD F | $10.62 2.81% 2.73% 2.5M
|
Health Technology
|
| O: 0.23%
H: 0.11%
C: -0.38%
disease extension therapeutics positive study
Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD
Published: 2023-02-02 (Crawled : 12:20) - globenewswire.com
CLSD P | $1.29 -2.27% -2.33% 230K
|
Health Technology
|
| O: 9.09%
H: 10.12%
C: -11.31%
cls-ax extension positive results study
Capricor Therapeutics Announces Positive 18-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy Patients
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
CAPR | $5.01 -0.79% -0.8% 350K
|
Health Technology
|
| O: -5.26%
H: 7.64%
C: 1.39%
cap-1002 ongoing label extension therapeutics duchenne positive results study
Altimmune Announces Positive Topline Results from 24-Week (12-Week Extension) Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)
Published: 2022-12-20 (Crawled : 12:20) - globenewswire.com
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -4.19%
H: 21.16%
C: 21.06%
liver disease topline trial positive results
SSR MINING ANNOUNCES POSITIVE EXPLORATION RESULTS AT MARIGOLD CREATING PATHWAYS FOR MINE PLAN ENHANCEMENT AND EXTENSION
Published: 2022-11-28 (Crawled : 12:20) - prnewswire.com
SSRM | News | $5.345 3.99% 3.84% 4.4M
|
Non-Energy Minerals
|
| O: -0.61%
H: 0.2%
C: -2.91%
extension positive
Ionis presents positive Phase 2 data from open label extension study of donidalorsen at 2022 ACAAI Annual Meeting
Published: 2022-11-13 (Crawled : 20:20) - prnewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.35%
H: 4.08%
C: 1.47%
label meeting extension positive study phase 2
SSR MINING ANNOUNCES POSITIVE EXPLORATION RESULTS FOR THE ÇAKMAKTEPE EXTENSION PROJECT (ARDICH), INCLUDING 28.3 METERS AT 8.23 G/T AU
Published: 2022-10-05 (Crawled : 12:00) - prnewswire.com
SSRM | News | $5.345 3.99% 3.84% 4.4M
|
Non-Energy Minerals
|
| O: -2.71%
H: 1.36%
C: 0.95%
extension positive
Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox
Published: 2022-07-22 (Crawled : 06:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
monkeypox label chmp vaccine extension positive
Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA)
Published: 2022-06-17 (Crawled : 17:00) - biospace.com/
SRRK 4 | $13.85 -0.72% -0.72% 710K
|
Health Technology
|
| O: 4.12%
H: 73.52%
C: 6.52%
extension trial positive muscular atrophy
Lipocine Announces Positive LPCN 1144 NASH Open Label Extension Study Results
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
LPCN | $5.33 -2.02% -2.06% 11K
|
Health Technology
|
| O: -5.19%
H: 2.7%
C: 0.26%
label positive results nash
Amryt Announces Positive Long-Term Safety and Efficacy Data for Mycapssa® (oral octreotide) from the 2nd Year of OPTIMAL Open Label Extension Study in Acromegaly Patients
Published: 2022-04-13 (Crawled : 17:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 1.45%
H: 3.5%
C: 0.65%
mycapssa label positive
Rhythm Pharmaceuticals Announces Positive Interim Data from Long-term Extension Study of Setmelanotide in Bardet-Biedl Syndrome (BBS)
Published: 2022-02-16 (Crawled : 13:00) - globenewswire.com
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: -1.33%
H: 1.34%
C: -1.04%
als positive setmelanotide set syndros
Meritor Announces Extension to Long-Term Standard Position Agreement with Wabash
Published: 2022-02-02 (Crawled : 23:00) - prnewswire.com
WNC | $25.36 1.32% 0.0% 730K
|
Producer Manufacturing
|
| O: -7.87%
H: 5.16%
C: 2.85%
MTOR | $36.5 -0.03%
|
Producer Manufacturing
|
| O: -1.1%
H: 5.46%
C: -0.9%
positive
SSR Mining Announces Positive Exploration Results for the Çakmaktepe Extension Project ("Ardich"), Including 40.7 Meters at 7.48 g/t Au
Published: 2021-08-18 (Crawled : 12:00) - prnewswire.com
SSRM | News | $5.345 3.99% 3.84% 4.4M
|
Non-Energy Minerals
|
| O: 0.12%
H: 0.31%
C: -2.3%
positive results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.